Project

Context

Hepatitis B virus (HBV) is a major global public health threat with over 257 million people worldwide.


Read More

Strategy

Stimulating innate signaling and inhibiting viral replication in infected hepatocytes.


Read More

Objectives

Perform a proof of concept clinical trial to evaluate novel immune modulators and their combination to boost...


Read More

Expected Results

Improve the functional cure rate in CHB and provide opportunities for finite duration curing therapies...


Read More

Benefits for medical experts

Benefits for patient


Benefits for community

IP-cure-B in numbers

Don't hesitate to contact us!


CONTACT US